Brief Exposure and Exercise for PTSD.
BEE for PTSD
Brief Exposure and Exercise Therapy for Post Traumatic Stress Disorder (PTSD)
1 other identifier
interventional
12
1 country
1
Brief Summary
The goal of this clinical trial is to learn if 8 sessions of brief exposure and exercise therapy works to treat Post Traumatic Stress Disorder (PTSD) in adults. This study will also learn if participants think brief exposure and exercise therapy is a good and doable treatment. and The main questions it aims to answer are:
- Do participants find brief exposure and exercise an acceptable and feasible means of treatment for PTSD?
- Does brief exposure and exercise decreases of the severity of PTSD symptoms? Participants will:
- Complete weekly questionnaires for 10-14 weeks.
- Attend 8 twice weekly exposure therapy and exercise sessions for 4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 25, 2025
CompletedFirst Submitted
Initial submission to the registry
July 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2026
CompletedApril 8, 2026
July 1, 2025
8 months
July 1, 2025
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in PTSD Checklist for DSM-5 (PCL-5)
The PCL-5 is a 20-item self-report questionnaire used to assess PTSD symptom severity. Each of the 20 PCL-5 items corresponds to symptoms of PTSD in the DSM-5. Items are rated on a Likert scale from 0 (not at all) to 4 (extremely) based upon how bothered participants are by each symptom. Items on the PCL-5 are summed, resulting in a total score of PTSD symptom severity from 0-80. Scores \>30 indicate probable PTSD.
Up to 15 weeks.
Patient Satisfaction Questionnaire Scores
Acceptability will be assessed using a patient satisfaction questionnaire. The 5 Items on the patient satisfaction questionnaire are rated on a 4 likert scale with higher scores on the indicating better perceptions of treatment. Total satisfaction of treatment can be obtained by averaging scores across the 5 items.
Once at end of treatment (up to 9 weeks).
Feasibility of the intervention
Feasibility will be analyzed by examining adherence to the treatment protocol checklist. An average score of 80% treatment adherence for all participants will be used as a threshold to define the feasibility of this intervention.
4 weeks of treatment following the 3-to 5-week baseline.
Secondary Outcomes (3)
Changes in Brief Experiential Avoidance Questionnaire
Up to 15 weeks
Changes in the posttraumatic cognitions inventory-9 (PTCI-9)
Up to 15 weeks.
Changes in the positive and negative valence affect schedule (PANAS)
Up to 15 weeks.
Study Arms (3)
Brief exposure therapy and exercise 3 week
EXPERIMENTALParticipants are randomized into the 3 week baseline condition before receiving the exposure therapy and exercise intervention.
Brief exposure therapy and exercise 5 week
EXPERIMENTALParticipants are randomized into the 5 week baseline condition before receiving the exposure therapy and exercise intervention.
Brief exposure therapy and exercise 4 week
EXPERIMENTALParticipants are randomized into the 4 week baseline condition before receiving the exposure therapy and exercise intervention.
Interventions
Treatment provided in this study includes an open label brief imaginal exposure therapy for Post Traumatic Stress Disorder (PTSD) and moderate intensity aerobic exercise (i.e., 70-75% max heart rate). Participants all receive 30 minutes of psychotherapy and 25 minutes of exercise.
Eligibility Criteria
You may qualify if:
- Provide informed consent and are willing to participate in therapy sessions twice weekly, which include moderate-intensity aerobic exercise.
- Participants must be adults aged 18-64 meeting the criteria for PTSD within the past month, who are not currently receiving treatment from other psychotherapy or are on unstable psychiatric medication (i.e., less than four weeks of psychiatric medication).
- Participants should be able to engage in 25 minutes of moderate-intensity aerobic exercise (i.e., 70-75% of max heart rate).
- Participants must be able to speak and read English fluently to participate in the current study.
You may not qualify if:
- Participants who endorse health condition(s) that would prevent moderate exercise.
- Participants who endorse (i.e., "yes") any items on the Physical Activity Readiness Questionnaire (PARQ) that is not controlled or managed.
- Participants with any injuries to the lower extremities that may hinder riding an exercise bicycle.
- Participants currently seeking or undergoing any other trauma-focused psychotherapy treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Troy Hubertlead
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jessica Burris, Ph.D.
University of Kentucky
- STUDY DIRECTOR
Shannon Sauer-Zavala, Ph.D.
University of Kentucky
- PRINCIPAL INVESTIGATOR
Troy J.J. Hubert, M.S.
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Graduate Research Assistant
Study Record Dates
First Submitted
July 1, 2025
First Posted
July 23, 2025
Study Start
June 25, 2025
Primary Completion
March 2, 2026
Study Completion
March 2, 2026
Last Updated
April 8, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- IPD and supporting information will be released before the completion of the first participant and stored after the completion of the study. Data analytic plan and analytic code will be stored on github indefinitely.
- Access Criteria
- The full de-identified dataset will be released by PI to other researchers upon request. The small de-identified dataset of variables used for primary analysis, the data dictionary, data analytic plan, and the R analytic code will be stored on Github and OSF.
De-identified data for participants will be shared. This includes data used for primary analysis, a data dictionary defining all variables, a data analytic plan, and R code used for analysis. All IPD will be hosted on OSF and Github.